PI3K Signaling in B Cell and T Cell Biology
Front Immunol
.
2014 Nov 3:5:557.
doi: 10.3389/fimmu.2014.00557.
eCollection 2014.
Authors
Klaus Okkenhaug
1
,
Martin Turner
1
,
Michael R Gold
2
Affiliations
1
Laboratory of Lymphocyte Signalling and Development, Babraham Institute , Cambridge , UK.
2
Department of Microbiology and Immunology, University of British Columbia , Vancouver, BC , Canada.
PMID:
25404931
PMCID:
PMC4217509
DOI:
10.3389/fimmu.2014.00557
No abstract available
Keywords:
B cell; PI3K pathway inhibitors; PI3K/AKT/mTOR; T cell; signal transduction.
Grants and funding
095691/WT_/Wellcome Trust/United Kingdom
BB/I01246X/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
BBS/E/B/000C0407/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom